CDC Publishes Article on Cutaneous Aspergillosis in Preterm Neonates
The CDC's Morbidity and Mortality Weekly Report featured the article on November 5, 2026, covering cases in Michigan and New York during 2023–2024.
The Centers for Disease Control and Prevention published an article titled "Cutaneous Aspergillosis Among Extremely Preterm Neonates in Neonatal Intensive Care Units — Michigan and New York, 2023–2024".
The article appeared in the CDC's Morbidity and Mortality Weekly Report on November 5, 2026, and describes cases among extremely preterm neonates in neonatal intensive care units in Michigan and New York during 2023–2024.
Loading comments…
The official source
Centers for Disease Control and Prevention
Cutaneous Aspergillosis Among Extremely Preterm Neonates in Neonatal Intensive Care Units — Michigan and New York, 2023–2024
The Centers for Disease Control and Prevention published "Cutaneous Aspergillosis Among Extremely Preterm Neonates in Neonatal Intensive Care Units — Michigan and New York, 2023–2024" in its Morbidity and Mortality Weekly Report on November 5, 2026.
Read the source →
Facts this version was allowed to use
- The Centers for Disease Control and Prevention published "Cutaneous Aspergillosis Among Extremely Preterm Neonates in Neonatal Intensive Care Units — Michigan and New York, 2023–2024" in its Morbidity and Mortality Weekly Report on November 5, 2026.
- The Centers for Disease Control and Prevention reported two clusters of cutaneous aspergillosis in neonatal intensive care units in Michigan and New York during 2023–2024.
- Cutaneous aspergillosis is a rare, life-threatening fungal infection in neonates, particularly in extremely preterm infants (gestational age <28 weeks).
- Outbreaks of cutaneous aspergillosis have been linked to environmental sources of Aspergillus species.
- The Michigan Department of Health and Human Services investigated a cluster of cutaneous aspergillosis in a neonatal intensive care unit in Michigan during 2023–2024.
- The New York State Department of Health investigated a cluster of cutaneous aspergillosis in a neonatal intensive care unit in New York during 2023–2024.
- In Michigan, two extremely preterm neonates (gestational age <24 weeks) received a diagnosis of cutaneous aspergillosis.
- Samples cultured from both infants in Michigan were positive for Aspergillus fumigatus.
- Both Michigan infants received antifungal treatment, and one infant died.
- In New York, three neonates received a diagnosis of cutaneous aspergillosis.
- Of the three New York neonates, two were born at gestational age 24–25 weeks and one at <24 weeks.
- Isolates from skin lesions of the New York neonates were identified as A. fumigatus (one isolate) and closely related Aspergillus quadrilineatus (two isolates).
- All three New York infants received antifungal treatment, and all three survived.
- In Michigan, A. fumigatus was isolated from an air sample collected near linen-transport areas.
- Environmental sampling was not performed in New York.
- No definitive environmental source was identified for either cluster.
- Both investigations led to targeted infection control interventions, including revised linen handling, optimized airflow and air-handling systems, and enhanced skin assessment and infection prevention practices.
- Clinicians should consider cutaneous aspergillosis in extremely preterm neonates with skin lesions.
- Early recognition and coordinated assessment by clinicians, infection preventionists, and facility engineers can guide mitigation, improve outcomes, and prevent additional cases.
Reader comments
Written by readers: not by Lens, its AI or the outlets it credits. Comments are screened before they show. Community rules
No comments yet. Be the first.